CB Scientific

Telehealth: CB Scientific (CBSC) Acquires Prevent Health Care International Corp.

CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business.
Dalrada

Adding Dalrada (DFCO) $0.09 to CoronaVirus Stock Watch List.

LIVE QUOTE Adding Dalrada (DFCO), a technology Incubator with interests in telehealth and...
Hapbee, Biotech Stock Review

Video: Hapbee Testimonials.

Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by...

Citius Pharma (CTXR) Video Presentation.

Chairman Leonard Mazur Discusses: Mino-Lok Treatment for Infected Catheters. Novellus Stem Cell Treatment...
Compass Pathways, Biotech Stock Review

Magic Mushroom Compass Pathways (CMPS) IPO Valued at Near $1 Billion.

Shares jumped 71% to $29 in New York after an initial public offering of 7.5 million shares priced at $17 each...
Sorrento Theraputics, Biotech STock Review

Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.

LIVE QUOTE Of course, we need not have to say, this is not an idea for widows...

Snowflake (SNOW) vs Facebook (FB) IPO.

Better to Wait a Year? Snowflake shares more than double. It's the biggest software IPO ever
aPHEX bIOcLEANSE

Hy-IQ Trademark

REGISTERED 9-15-2020

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...

Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.

Interesting Charts From the Day we Discovered it. Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced...

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Added Citius to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...